Amyris Inc. [AMRS] has traded in a range of $1.40 to $6.07 in the last 1 year. As of this writing, the stock is at $2.59, down -5.66%. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement. Over the last week, AMRS shares are 4.58% up with the monthly amount drift of 4.98% and seems well in a long time frame.
On 3, December 2020, Amyris Launches Virtual Investor Mini-Series. According to news published on Yahoo Finance, Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced today that it will be launching a virtual investor mini-series themed “Delivering on the Promise of Synthetic Biology”.
Analyst Birdseye View:
The most recent analyst activity for Amyris Inc. [NASDAQ:AMRS] stock was on November 25, 2020, when it was Initiated with a Market perform rating from Cowen, which also raised its 12-month price target on the stock to $5. Before that, on November 25, 2020, Jefferies Recapitulated a Buy rating and elevated its amount target to $3.35. On December 12, 2019, Oppenheimer Initiated an Outperform rating and boosted its price target on this stock to $8. On November 14, 2018, B. Riley FBR Reiterated a Buy rating and decreased its price target from $10 to $8. On January 25, 2018, B. Riley FBR Inc. Initiated a Buy rating and increased its price target to $8. On May 28, 2014, Stifel Resumed a Hold rating. On February 10, 2012, Deutsche Bank Downgrade a Hold rating and decreased its target amount on this stock from $20 to $9. On November 02, 2011, Robert W. Baird Downgrade a Neutral rating and amplified its amount target to $16.
In the past 52 weeks of trading, this stock has oscillated between a low of $1.40 and a peak of $6.07. Right now, according to Wall Street analyst the average 12-month amount target is $6.34. At the most recent market close, shares of Amyris Inc. [NASDAQ:AMRS] were valued at $2.59.
Amyris Inc. [NASDAQ:AMRS] most recently reported quarterly sales of 34.26 billion, which represented growth of -2.00%. This publicly-traded organization’s revenue is $271,938 per employee, while its income is -$419,585 per employee. This company’s Gross Margin is currently 37.70%, its Pretax Margin is -158.72, and its Net Margin is -154.29. Continuing to look at profitability, this corporation’s Return on Assets & Whole Principal is sitting at -162.96 and -658.23 respectively.
If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 754.98 and the whole liability to whole assets at 179.58. It shows enduring liability to the whole principal at 567.20 and enduring liability to assets at 1.35 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 2.65 points at 1st support level, the second support level is making up to 2.57. But as of 1st resistance point, this stock is sitting at 2.80 and at 2.86 for 2nd resistance point.
Amyris Inc. [AMRS] reported its earnings at -$0.41 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.17/share signifying the difference of -0.24 and -141.20% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.56 calling estimates for -$0.19/share with the difference of -0.37 depicting the surprise of -194.70%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Amyris Inc. [NASDAQ:AMRS] is 1.30. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.00. Now if looking for a valuation of this stock’s amount to sales ratio it’s 2.05.
The most recent insider trade was by Kung Frank, Director, and it was the purchase of 3.69 million shares on Jun 05. DOERR L JOHN, the Director, completed a purchase of 52785.0 shares on Feb 19. On Feb 19, Melo John, President and CEO, completed a sale of 52875.0 shares.